3639 results for «247»
3639 results
PFO closure - Progression in practice
20 May 2026 – From EuroPCR 2026
This session presents progressive insights into patent foramen ovale (PFO) closure, comparing outcomes across age groups and evaluating residual shunting via transcranial Doppler. It highlights tailored antiplatelet therapy durations from the PROLONG registry, long-term safety and efficacy data, morphological variations of the fossa ovalis, and the...
First-in-human studies in cardiovascular devices: from first 10 patients to global innovation — How efficient early studies advance emerging technologies
20 May 2026 – From EuroPCR 2026
Understand the pivotal role of first-in-human studies in advancing cardiovascular device innovation through operational insights from early patient experiences. This session reviews cutting-edge technologies including percutaneous left ventricular assist devices, transcatheter leaflet augmentation, physiology-guided PCI, synchronized diaphragmatic stimulation, pulmonary artery denervation, and perspectives on translating early...
Mitral paravalvular leak closure: case-bases strategies
20 May 2026 – From EuroPCR 2026
This session presents case-based strategies for mitral paravalvular leak closure, highlighting complex percutaneous approaches including multivalvular failure management, apical access techniques, and transatrial direct surgical valve-in-MAC procedures. It features challenging clinical scenarios demonstrating innovative solutions for hemolytic leaks and complex paravalvular defects.
How to safely perform a retrograde CTO PCI: step-by-step guidance
20 May 2026 – From EuroPCR 2026
This session offers step-by-step guidance on safely performing retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI). It covers the fundamentals of retrograde setup and collateral crossing, execution of a controlled reverse CART technique, and addresses common pitfalls with practical tips to improve procedural success and...
Prognostics elements on multivessel disease and coronary artery disease
20 May 2026 – From EuroPCR 2026
This session examines key prognostic elements in multivessel and coronary artery disease, featuring studies on mechanical circulatory support across LDL-C levels, biomarkers impacting periprocedural myocardial infarction, autologous cell therapy outcomes for refractory angina, and novel risk stratification indices. It also addresses prognosis in cancer patients and...
New evidence for coronary physiology in epicardial disease
20 May 2026 – From EuroPCR 2026
Explore new evidence in coronary physiology related to epicardial disease through analyses of landmark trials and registries. Topics include five-year follow-up data from DEFINE-FLAIR and iFR-SWEDEHEART, complete revascularization in elderly myocardial infarction patients, angiography-derived versus pressure wire assessments, prognostic implications of CT angiography-derived physiology, and the...
From entry to exit: managing arterial access for nurses and allied professionals
20 May 2026 – From EuroPCR 2026
This session focuses on arterial access management tailored for nurses and allied health professionals. It highlights key anatomical landmarks, demonstrates the purpose and use of common vascular closure devices through live manikin demonstrations, and discusses the essential role of nursing and allied staff in vascular access...
Expect the unexpected when treating calcified lesions
20 May 2026 – From EuroPCR 2026
Addressing the unexpected challenges in treating calcified lesions, this session showcases novel combined strategies for managing distal small-vessel coronary perforations, alongside complex case studies involving perforations, dissections, and stent complications related to calcified nodules. It provides valuable insights into rescue techniques and complication management to improve...
Routine primary PCI: what can go wrong?
21 May 2026 – From EuroPCR 2026
This session offers an in-depth examination of potential complications during routine primary PCI, focusing on prevention and management strategies. Key learning points include understanding no-reflow phenomena, managing STEMI in post-CABG patients, and handling thrombus burden effectively. Real-world cases illustrate decision-making processes and therapeutic approaches to optimize...
Challenging transcatheter interventions for mitral stenosis and mitral annular calcification
21 May 2026 – From EuroPCR 2026
This session addresses the challenges of transcatheter interventions in severe mitral stenosis and mitral annular calcification. It highlights therapeutic innovations such as treating mitral stenosis with annular calcification, valve-in-MAC procedures, use of extra-large Myval valves, transatrial ViMAC approaches, and combined multivalve interventions in rheumatic heart disease.
Insight from recent evidence in coronary artery disease: value of DCB for de novo lesions (SELUTION) and imaging for left main PCI (OPTIMAL)
21 May 2026 – From EuroPCR 2026
This session reviews pivotal recent evidence impacting daily practice in coronary artery disease management. It discusses the role of drug-coated balloons (DCB) for de novo lesions as evaluated in the SELUTION trial and evaluates intracoronary imaging strategies for left main PCI as presented in the OPTIMAL...
Imaging-guided CTO PCI
21 May 2026 – From EuroPCR 2026
This session focuses on imaging-guided CTO PCI, presenting cases that illustrate the utility of OCT, CT, and IVUS for lesion assessment and procedural guidance. Topics include woven-like CTOs, double CTO evaluation, management of late stent malapposition, and strategies for navigating complex occlusions to optimize outcomes.
The structural bailout playbook: managing complications
21 May 2026 – From EuroPCR 2026
The session presents a practical structural bailout playbook focused on managing complex complications during structural heart interventions. It features challenging cases such as unusual atrial septal defect closure complications, navigation of a displaced patent ductus arteriosus stent in infants, percutaneous closure of mitral paravalvular leaks with...
Refining PCI plannings and decision-making with novel technologies
21 May 2026 – From EuroPCR 2026
This session highlights cutting-edge technologies that enhance PCI planning and decision-making. It covers the clinical populations benefiting from QFR-guided revascularisation, prognostic insights from radial wall strain in DCB-treated vessels, and advances in artificial intelligence and machine learning to assess ischemia and predict PCI outcomes, especially in...
Complication two: PCI complications occurring during PCI for NSTEMI
21 May 2026 – From EuroPCR 2026
This session addresses the spectrum of PCI complications encountered during NSTEMI interventions, including coronary perforations, challenges with unexpanded covered stents, IVUS-related issues, giant coronary aneurysms at bifurcations, and distal wire perforations, providing critical lessons in complication management and operator coordination.
Optimising TAVI care pathways
21 May 2026 – From EuroPCR 2026
This session examines innovations in TAVI care pathways aimed at improving patient outcomes and healthcare efficiency. Topics include large-scale transatlantic data on day-case TAVI, standardized ECG conduction algorithms reducing hospital stay, nurse-led structured pathways, feasibility of very early discharge, and urgent outpatient TAVI for severe aortic...
Optimising the results of non-left main bifurcation PCI
21 May 2026 – From EuroPCR 2026
This session focuses on optimizing outcomes in non-left main bifurcation PCI by emphasizing lesion preparation and stent sizing guided by intravascular imaging. It integrates physiological and imaging assessments for confident final result evaluation and discusses criteria for selecting upfront two-stent strategies in bifurcation lesions.
Advancing TAVI practice
21 May 2026 – From EuroPCR 2026
Advancing TAVI practice is the focus of this session, addressing antiplatelet therapy choices, novel transcatheter treatments for pure aortic regurgitation, early hemodynamic valve deterioration as a prognostic marker, prosthesis-patient mismatch in redo-TAVI, pioneering valve-in-mechanical valve interventions, and comprehensive core-lab evaluation of implantation depth and clinical outcomes.
TAVI procedural complications - Part 7: coronary protection, valve embolisation, and more
21 May 2026 – From EuroPCR 2026
This session addresses complex procedural complications in TAVI, featuring challenging cases such as rupture of the sinus of Valsalva, innovative bailouts for valve embolisation, mechanisms of aorta-right ventricular fistula post-TAVI, and management strategies for failed surgical aortic valves after endocarditis.
TAVI - Procedural strategy
21 May 2026 – From EuroPCR 2026
This session focuses on procedural strategies for TAVI, examining the influence of coronary artery disease severity on PCI decision-making, revascularisation approaches in high-bleeding risk patients, the role of CT imaging and implant depth in procedural planning, and comparative evaluation of pre-dilatation versus direct valve implantation in...
